Boston Scientific (BSX) Tax Provisions (2009 - 2026)

Boston Scientific (BSX) has 18 years of Tax Provisions data on file, last reported at -$176.0 million in Q1 2026.

• For the quarter ending Q1 2026, Tax Provisions fell 232.33% year-over-year to -$176.0 million; the trailing twelve-month figure through Mar 2026 stood at $183.0 million (down 59.69% YoY), and the FY2025 full-year result was $493.0 million, up 13.07% from the prior year.
• Tax Provisions slipped to -$176.0 million in Q1 2026, from $30.0 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $255.0 million in Q4 2022 to a low of -$176.0 million in Q1 2026.
• A 5-year average of $93.4 million and a median of $105.0 million in 2023 frame the typical range for Tax Provisions.
• Across the five-year window, Tax Provisions jumped 2200.0% in 2024 and plunged 232.33% in 2026, its largest moves.
• Tracing BSX's Tax Provisions over 5 years: stood at $255.0 million in 2022, then slumped by 99.61% to $1.0 million in 2023, then jumped by 2200.0% to $23.0 million in 2024, then soared by 30.43% to $30.0 million in 2025, then slumped by 686.67% to -$176.0 million in 2026.
• Business Quant data shows BSX's Tax Provisions at -$176.0 million in Q1 2026, $30.0 million in Q4 2025, and $183.0 million in Q3 2025.